MSFHR commits $1.5M to SPOR Networks in Chronic Disease

7 April 2016

Researchers working to improve the health of Canadians living with chronic diseases received a major funding boost recently with the launch of five new national networks.

A total of $62.25 million will be invested by the Canadian Institutes of Health Research to establish the SPOR Networks in Chronic Disease, which will connect researchers, health professionals, policy-makers, and patients across the country. Additional funding of $126 million will be provided by a wide range of partner organizations, including universities, hospitals, industry, health charities, and provincial agencies.

MSFHR is pleased to commit $1.5 million over five years to support the BC-based research activities of three networks:

  • Can-SOLVE CKD, led by Dr. Adeera Levin (2015 Aubrey J. Tingle Prize recipient), will be based at the University of British Columbia and will aim to reduce the number of people with chronic kidney disease who need dialysis or organ transplants.
  • CHILD-BRIGHT, based at McGill University, will help children with brain-based developmental disabilities achieve better health outcomes. Dr. Steven Miller (2006 MSFHR Scholar) is a co-investigator with this team.
  • The SPOR Network in Diabetes and its Related Complications is based at the University of Toronto and aims to connect care providers, patients, and specialists to achieve improved diabetes treatment.

Two additional networks will focus on chronic pain and gastrointestinal disorders, respectively.

“These networks will produce innovations that improve the health of Canadians and position Canada as a global leader in research on these chronic diseases,” said CIHR president Dr. Alain Beaudet in a press release. “We thank all the partners supporting these networks for their strong commitment and generous contributions.”

The networks are a core element of CIHR’s Strategy for Patient-Oriented Research, which is dedicated to integrating research into patient care and the health care system. Patients were involved in shaping each network’s research agenda, in collaboration with researchers, to ensure alignment with patient needs and priorities.

Read more: